Lipid nanoparticles deliver one-two punch to shrink resistant oral tumors in preclinical models

Дата публикации: 23-07-2026 16:00:02

Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and the number of new cases is predicted to rise by 30% in the next decade. Despite decades of cancer research, treating OSCC remains a challenge. The five-year survival rate is approximately 50%, and standard treatments such as ablative surgery and radiation often leave patients with permanent disfigurement or profound, lifelong impairment of essential oral functions such as speaking and swallowing.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	A One-Two Punch: Using Lipid Nanoparticles to Transform Oral Cancer Treatment	0	8.25	27-07-2026
2	Immunotherapy in Head and Neck Squamous Cell Carcinoma With PD-L1 Combined Positive Score of Less Than 1	0	12.19	17-09-2026
3	Is Antigen-Specific Immunotherapy a New Frontier in HPV-Initiated Head and Neck Cancer?	0	10.94	17-09-2026
4	Acid-resistant nanocage shows promise for targeted gastric cancer therapy	0	9.81	20-07-2026
5	Cost-Effectiveness of Perioperative Pembrolizumab in Locally Advanced Head and Neck Cancer	0	7	02-07-2026
6	Ultrasensitive blood test predicts head and neck cancer relapse months earlier	5	7	10-06-2026
7	Más de 300 casos al año en Málaga: un nuevo fármaco arroja luz frente al cáncer de páncreas	2	6	12-07-2026
8	New brush test detects oral cancer in one hour	7	8	06-07-2026
9	Blood Manganese and Risk of Squamous Cell Carcinomas of the Head and Neck	0	7	02-07-2026
10	Ronquera, dificultad para tragar o un bulto en el cuello: cuándo pueden ser una señal de alarma de cáncer	0	7.3	27-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.5. Источник: phys.org.